MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Acute administration of methylphenidate modulates functional connectivity during the processing of irrelevant stimuli in Parkinson’s disease patients

    N. Fogelson, L. Li, B. Tan, E. Martinez Lopez, M. Roson Gonzalez, M. Fernandez Delolmo, T. Gurevich, L. Vela Desojo (Fuenlabrada, Spain)

    Objective: Examine the effects of a single dose of methylphenidate (MPD), on event-related functional connectivity (FC), in patients with Parkinson’s disease (PD). Background: Recent studies…
  • 2026 International Congress

    Mild Motor Impairments in Rapid Eye Movement Behavior Disorder: Tremor and Bradykinesia

    JH. Lee, ER. Tobin, EA. Christou, XY. Lou, M. Louis, LH. Le, MF. Presti, MS. Jaffee, DE. Vaillancourt (Gainesville, USA)

    Objective: We investigated patients with RBD to identify mild motor impairments through the objective quantification of sensitive motor control assays. Background: It is established that…
  • 2026 International Congress

    Exploratory Results From a Phase 1 Study of NIO752 in Progressive Supranuclear Palsy Supporting Further Clinical Studies

    M. Brys, M-A. Valentin, S. Menon, N. Pezous, M. Meadowcroft, H. Gunduz-Bruce, C. Serban, L. Kovacic, M-E. Riviere, D. Singh Juneja, A. Graf, L. Vandevrede, G. Höglinger (East Hanover, USA)

    Objective: To report exploratory analyses of biomarker and clinical outcomes from a first-in-human study of NIO752 in progressive supranuclear palsy (PSP) and provide rationale for…
  • 2026 International Congress

    Predicting Parkinson’s: Navigating Risk, Rights, and Regulation

    J. Braun, B. Schmitz-Luhn (Bonn, Germany)

    Objective: This study explores the legal and ethical challenges surrounding predictive testing for Parkinson’s disease (PD), with a particular focus on its impact in employment,…
  • 2026 International Congress

    Can a slogan poster featuring the patient’s primary physician help improve gait and prevent falls at home in patients with Parkinson’s disease?

    Y. Okuma (Izunokuni, Japan)

    Objective: To present cases with Parkinson’s disease (PD) suggesting that a slogan poster aimed at improving gait and preventing falls may be effective. Background: Patients…
  • 2026 International Congress

    Proposal of Anatomo-Functional Tremor Patterns for Ultrasound-Guided Botulinum Toxin Infiltration

    G. Salazar, I. Caballero (Terrassa, Spain)

    Objective: To propose a practical anatomo-functional framework for ultrasound-guided BoNT-A infiltration in upper limb tremor based on tremor biomechanics. Background: Botulinum toxin type A (BoNT-A)…
  • 2026 International Congress

    Real-world database analysis of new-onset hypotension and medications for orthostatic hypotension prescribing patterns in patients with Parkinson’s Disease receiving MAO-B Inhibitors and levodopa in Japan

    M. Nagai, R. Ando, K. Sasaki, Y. Tomita, K. Daidoji, Y. Kogo, T. Ishida (Ehime, Japan)

    Objective: To evaluate the incidence of claims-defined new-onset hypotension and the prescribing patterns of medications for orthostatic hypotension in patients with Parkinson’s disease (PD) treated…
  • 2026 International Congress

    Suicidal Ideation and the Hippocampal Histaminergic System in Huntington’s Disease: A PET Study

    P. Eze, C. Madrigal-Esquivel, O. Makos, A. Rangel-Cristales, J. Valera-Bermejo, M. Moretto, N. Martin, P. Tall, J. Staunton, M. Hartmann, F. Turkheimer, J. Badenoch, M. Veronese, N. Palasits, A. Wood, S. Williams, D. van Wamelen (London, United Kingdom)

    Objective: To determine whether presence and severity of suicidal ideation (SI) are associated with hippocampal volume and histamine H3 receptor (H3R) PET uptake in people with Huntington’s disease (PwHD). Background: Suicidal ideation occurs in approximately 8–27% of PwHD, yet its causes remain unclear​(1–3)​. The…
  • 2026 International Congress

    Integrated and Multidisciplinary Care for Older Adults with Parkinson’s Disease: A value-driven approach

    P. Venugopalan Menon, M. Tan, W. Hong, E. Gondo Santoso, S. Kumari, A. Soh, S. Kumar Seetharaman (Singapore, Singapore)

    Objective: To evaluate value driven outcomes of an integrated multidisciplinary Parkinson’s clinic for older adults in Singapore Background: Parkinson’s Disease (PD) is a complex neurodegenerative…
  • 2026 International Congress

    Comparative efficacy and safety of Safinamide versus Opicapone in Japanese patients with Parkinson’s Disease and wearing-off: A matching-adjusted indirect comparison

    N. Nishikawa, R. Ando, T. Ishida, T. Hatano, N. Hattori, M. Nomoto (Tokyo, Japan)

    Objective: To compare efficacy and safety outcomes with safinamide and opicapone as adjuncts to levodopa in Parkinson’s disease (PD) patients with wearing-off using an anchored…
  • « Previous Page
  • 1
  • …
  • 80
  • 81
  • 82
  • 83
  • 84
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley